United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $506.59 +1.37%
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Cost of product sales: 23.6M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
